Highlights
The LEGEND trial found that a high-sensitivity troponin-based rule-out strategy reduced hospital length of stay by 3.6 hours, increased early discharges by 22.9%, and decreased cardiac testing by 7.8% without compromising patient safety.
The LEGEND trial found that a high-sensitivity troponin-based rule-out strategy reduced hospital length of stay by 3.6 hours, increased early discharges by 22.9%, and decreased cardiac testing by 7.8% without compromising patient safety.